Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

P site

An early observation that 2 -d-3 -AMP was a more potent inhibitor of adenylyl cyclases than 2 -d-Ado suggested that the enzyme would accept substitutions at the 3 -ribose position and that phosphate was particularly well tolerated. This led to the generation of a family of 3 -phosphoryl derivatives of 2, 5 -dideoxyadenosine exhibiting ever greater inhibition with the addition of an increasing number of 3 -phosphoryl groups, the most potent of which is 2, 5 -dideoxyadenosine-3 -tetraphosphate (2, 5 -dd-3 -A4P Table 4) [5]. These constitute a class of inhibitors historically referred to as P -site ligands that caused inhibition of adenylyl... [Pg.34]

Cre is a bacterial recombinase (cre=causes recombination), which recognizes loxP sites of bacteriophage P. If two loxP (loxP= locus of x-ing over of bacteriophage P) sites have a parallel orientation, the DNA segment between these sites will be deleted by the action of the Cre recombinase. [Pg.396]

P-site ligands inhibit adenylyl cyclases by a noncompetitive, dead-end- (post-transition-state) mechanism (cf. Fig. 6). Typically this is observed when reactions are conducted with Mn2+ or Mg2+ on forskolin- or hormone-activated adenylyl cyclases. However, under- some circumstances, uncompetitive inhibition has been noted. This is typically observed with enzyme that has been stably activated with GTPyS, with Mg2+ as cation. That this is the mechanism of P-site inhibition was most clearly demonstrated with expressed chimeric adenylyl cyclase studied by the reverse reaction. Under these conditions, inhibition by 2 -d-3 -AMP was competitive with cAMP. That is, the P-site is not a site per se, but rather an enzyme configuration and these ligands bind to the post-transition-state configuration from which product has left, but before the enzyme cycles to accept new substrate. Consequently, as post-transition-state inhibitors, P-site ligands are remarkably potent and specific inhibitors of adenylyl cyclases and have been used in many studies of tissue and cell function to suppress cAMP formation. [Pg.1038]

NeuAc, N-acetylneuraminic acid Cer, ceramide Gic, giucose Gai, gaiactose. -p, site of deficient enzyme reaction. [Pg.203]

The process of RNA synthesis in bacteria—depicted in Figure 37-3—involves first the binding of the RNA holopolymerase molecule to the template at the promoter site to form a PIC. Binding is followed by a conformational change of the RNAP, and the first nucleotide (almost always a purine) then associates with the initiation site on the 3 subunit of the enzyme. In the presence of the appropriate nucleotide, the RNAP catalyzes the formation of a phosphodiester bond, and the nascent chain is now attached to the polymerization site on the P subunit of RNAP. (The analogy to the A and P sites on the ribosome should be noted see Figure... [Pg.343]

The binding of the 60S ribosomal subunit to the 48S initiation complex involves hydtolysis of the GTP bound to elF-2 by elF-5. This teaction tesults in telease of the initiation factots bound to the 48S initiation complex (these factots then ate tecycled) and the tapid association of the 40S and 60S subunits to fotm the 80S ribosome. At this point, the met-tRNA is on the P site of the ribosome, ready for the elongation cycle to commence. [Pg.367]

The a-amino group of the new aminoacyl-tRNA in the A site carries out a nucleophilic attack on the esterified carboxyl group of the peptidyl-tRNA occupying the P site (peptidyl or polypeptide site). At initiation, this site is occupied by aminoacyl-tRNA mef. This reaction is catalyzed by a peptidyltransferase, a component of the 285 RNA of the 605 ribosomal subunit. This is another example of ribozyme activity and indicates an important—and previously unsuspected—direct role for RNA in protein synthesis (Table 38-3). Because the amino acid on the aminoacyl-tRNA is already activated, no further energy source is required for this reaction. The reaction results in attachment of the growing peptide chain to the tRNA in the A site. [Pg.368]

The now deacylated tRNA is attached by its anticodon to the P site at one end and by the open GGA tail to an exit (E) site on the large ribosomal subunit (Figure 38-8). At this point, elongation factor 2 (EE2) binds to and displaces the peptidyl tRNA from the A site to the P site. In turn, the deacylated tRNA is on the E site, from which it leaves the ribosome. The EF2-GTP complex is hydrolyzed to EF2-GDP, effectively moving the mRNA forward by one codon and leaving the A site open for occupancy by another ternary complex of amino acid tRNA-EFlA-GTP and another cycle of elongation. [Pg.368]

Figure 38-8. Diagrammatic representation of the peptide elongation process of protein synthesis. The small circles labeled n - 1, n, n -I-1, etc, represent the amino acid residues of the newly formed protein molecule. EFIA and EF2 represent elongation factors 1 and 2, respectively. The peptidyl-tRNA and aminoacyl-tRNA sites on the ribosome are represented by P site and A site, respectively. Figure 38-8. Diagrammatic representation of the peptide elongation process of protein synthesis. The small circles labeled n - 1, n, n -I-1, etc, represent the amino acid residues of the newly formed protein molecule. EFIA and EF2 represent elongation factors 1 and 2, respectively. The peptidyl-tRNA and aminoacyl-tRNA sites on the ribosome are represented by P site and A site, respectively.
Figure 38-9. Diagrammatic representation of the termination process of protein synthesis. The peptidyl-tRNAand aminoacyl-tRNA sites are indicated as P site and A site, respectively. The termination (stop) codon is indicated by the three vertical bars. Releasing factor RF1 binds to the stop codon. Releasing factor RF3, with bound GTP, binds to RFl. Flydrolysisofthe peptidyl-tRNA complex is shown by the entry of HjO. N and C indicate the amino and carboxyl terminal amino acids, respectively, and illustrate the polarity of protein synthesis. Figure 38-9. Diagrammatic representation of the termination process of protein synthesis. The peptidyl-tRNAand aminoacyl-tRNA sites are indicated as P site and A site, respectively. The termination (stop) codon is indicated by the three vertical bars. Releasing factor RF1 binds to the stop codon. Releasing factor RF3, with bound GTP, binds to RFl. Flydrolysisofthe peptidyl-tRNA complex is shown by the entry of HjO. N and C indicate the amino and carboxyl terminal amino acids, respectively, and illustrate the polarity of protein synthesis.
The charging of the tRNA molecule with the aminoacyl moiety requires the hydrolysis of an ATP to an AMP, equivalent to the hydrolysis of two ATPs to two ADPs and phosphates. The entry of the aminoacyl-tRNA into the A site results in the hydrolysis of one GTP to GDP. Translocation of the newly formed pep-tidyl-tRNA in the A site into the P site by EF2 similarly results in hydrolysis of GTP to GDP and phosphate. Thus, the energy requirements for the formation of one peptide bond include the equivalent of the hydrolysis of two ATP molecules to ADP and of two GTP molecules to GDP, or the hydrolysis of four high-energy phosphate bonds. A eukaryotic ribosome can incorporate as many as six amino acids per second prokaryotic ribosomes incorporate as many as 18 per second. Thus, the process of peptide synthesis occurs with great speed and accuracy until a termination codon is reached. [Pg.370]

The a- and P-domains have been isolated in order to study their role in the two reaction phases. The slow reactions occur predominately with the P-domain while the fast reaction is associated entirely with the a-domain [106]. This pattern follows other circumstances where the a-domain is more reactive than the P-domain. However, the P Site has Cd ions that are thermodynamically less tightly bound and more labile to inter-site exchange. [Pg.299]

A universal postmortem hallmark of Alzheimer s disease (AD) is the presence of amyloid plaques in the brain. These plaques are mainly composed of a 39 to 42 amino acid peptide, referred to as A0 peptide, that is excised from a precursor protein, amyloid precursor protein (APP), by the sequential action of two proteases (Olsen et al., 2001). The first of the two cleavages of APP occurs at a site within the APP protein that is termed the P-site, and BACE has been clearly determined to be the enzyme responsible for this cleavage event. A small portion of the AD patient... [Pg.167]

In the following section, we describe protocols for tests aimed at screening for compounds capable of interfering with some of the main activities of this factor, such as (a) recognition and binding of initiator tRNA (b) codon-dependent ribosomal binding of fMet-tRNA leading to the formation of a 30S or 70S initiation complex (c) ribosome-dependent hydrolysis of GTP and (d) accommodation of fMet-tRNA in the ribosomal P-site and formation of the first peptide bond (initiation dipeptide formation). [Pg.290]

Dinos, G., Wilson, D. N., Teraoka, Y., Szaflarski, W., Fucini, P., Kalpaxis, D., and Nierhaus, K. H. (2004). Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin The universally conserved residues G693 and C795 regulate P-site RNA binding. Mol. Cell 13, 113-124. [Pg.328]

The displacements of the Si and P atoms are also important. In all cases, the silicon moves substantially away from the P-site, into or through the triangular plane formed by the neighboring silicons. The phosphorus is found to move away from the Si-site, except in the local-density calculations, where it moves in the same direction as the silicon. [Pg.552]

The P-site of adenylyl cyclase inhibits cyclic AMP accumulation 308 There are four adenosine receptor subtypes 308 Xanthines block P2 but not P2 receptors 309... [Pg.303]

The P-site of adenylyl cyclase inhibits cyclic AMP accumulation. Since P, and P2 receptors are located on the cell surface, they bind purines or pyrimidines in the extracellular space. There also is an adenosine binding site located intracellularly on the enzyme adenylyl cyclase (see Ch. 21). This is referred to as the P-site of adenylyl cyclase. Binding of adenosine and other purines, notably 3 AMP, 2 deoxy-3 -ATP and 2, 5 -dideoxyadenosine to this site, inhibits adenylyl cyclase activity [8]. The P-site of adenylyl cyclase and other intracellular purine binding sites are not classified as purinergic receptors. [Pg.308]

Figure 4.32 A space-filling model of the 70S ribosome the three RNA molecules—5S, 16S and 23 S—are in white, yellow and purple, respectively ribosomal proteins of the large and small subunit are in blue and green, respectively the tRNA in the A-site, with its 3 -end extending into the peptidyl-transferase cavity is in red and the P-site tRNA is in yellow. (From Moore and Steitz, 2005. Copyright (2005) with permission from Elsevier.)... Figure 4.32 A space-filling model of the 70S ribosome the three RNA molecules—5S, 16S and 23 S—are in white, yellow and purple, respectively ribosomal proteins of the large and small subunit are in blue and green, respectively the tRNA in the A-site, with its 3 -end extending into the peptidyl-transferase cavity is in red and the P-site tRNA is in yellow. (From Moore and Steitz, 2005. Copyright (2005) with permission from Elsevier.)...

See other pages where P site is mentioned: [Pg.288]    [Pg.447]    [Pg.447]    [Pg.687]    [Pg.495]    [Pg.32]    [Pg.1038]    [Pg.1038]    [Pg.1038]    [Pg.1086]    [Pg.1087]    [Pg.1090]    [Pg.1500]    [Pg.370]    [Pg.170]    [Pg.172]    [Pg.172]    [Pg.488]    [Pg.53]    [Pg.53]    [Pg.285]    [Pg.288]    [Pg.73]    [Pg.74]    [Pg.75]    [Pg.235]    [Pg.316]    [Pg.362]    [Pg.48]    [Pg.117]    [Pg.2]    [Pg.2]   
See also in sourсe #XX -- [ Pg.365 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.742 , Pg.744 ]

See also in sourсe #XX -- [ Pg.742 , Pg.744 ]




SEARCH



Human Retaining P-Glucosidase Active Site Residues

P site bonds

P-Site Ligands

Ribosomes P site

TRNA binding sites P-site

© 2024 chempedia.info